Analysts / Report Coverage

Paras Biopharmaceuticals in Analysts / Report Coverage
Competitor Analysis: Paras Biopharmaceuticals to raise EUR 10m - EUR 20m with a view to mid-term IPO, MergerMarket, UK, 2014
Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies, Research and Markets, Ireland, 2014
Type 2 Diabetes: Pipeline Review, Global Market Direct, USA, 2014
Metastatic Prostate Cancer: Pipeline review, Research and Markets, Ireland, 2014
Post Menopausal Osteoporosis: Pipeline review,Global Market Direct, USA, 2014
Competitor Analysis Report: PTH Receptor Agonists, TeriparatideBiosimilars and Biosuperiors, Research and Markets,Ireland, 2013